Swiss drugs regulator authorises Pfizer/Biontech COVID-19 … – Thomson Reuters Foundation

(Adds details and background)
ZURICH, Dec 19 (Reuters) – Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday, calling it the world’s first such approval under a standard procedure.
Two months after receiving the application, Swissmedic granted authorisation for the vaccine in a rolling review of documents being submitted.
Other countries have already approved it for emergency use to help curb the global coronavirus pandemic.
…

Click here to view the original article.